[go: up one dir, main page]

DE69327529D1 - Immunologisch mit HLA homologe HIV Protein Epitope - Google Patents

Immunologisch mit HLA homologe HIV Protein Epitope

Info

Publication number
DE69327529D1
DE69327529D1 DE69327529T DE69327529T DE69327529D1 DE 69327529 D1 DE69327529 D1 DE 69327529D1 DE 69327529 T DE69327529 T DE 69327529T DE 69327529 T DE69327529 T DE 69327529T DE 69327529 D1 DE69327529 D1 DE 69327529D1
Authority
DE
Germany
Prior art keywords
hiv protein
protein epitopes
hla
epitopes
homologous hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327529T
Other languages
English (en)
Other versions
DE69327529T2 (de
Inventor
Alberto Beretta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondation Mondiale Recherche et Prevention Sida
Original Assignee
Fondation Mondiale Recherche et Prevention Sida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondation Mondiale Recherche et Prevention Sida filed Critical Fondation Mondiale Recherche et Prevention Sida
Publication of DE69327529D1 publication Critical patent/DE69327529D1/de
Application granted granted Critical
Publication of DE69327529T2 publication Critical patent/DE69327529T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69327529T 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope Expired - Fee Related DE69327529T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
PCT/IT1993/000049 WO1993023427A1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla

Publications (2)

Publication Number Publication Date
DE69327529D1 true DE69327529D1 (de) 2000-02-10
DE69327529T2 DE69327529T2 (de) 2000-08-10

Family

ID=11400995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327529T Expired - Fee Related DE69327529T2 (de) 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope

Country Status (7)

Country Link
US (2) US6042831A (de)
EP (1) EP0641357B1 (de)
AT (1) ATE188484T1 (de)
CA (1) CA2135630C (de)
DE (1) DE69327529T2 (de)
IT (1) IT1254360B (de)
WO (1) WO1993023427A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
IT1264078B1 (it) * 1993-09-10 1996-09-10 San Romanello Centro Fond Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
WO2017152144A1 (en) * 2016-03-03 2017-09-08 Duke University Swarm immunization with envelopes from ch505

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
JPH05506669A (ja) * 1990-09-25 1993-09-30 ペプテック　（ユーケイ）　リミテッド エイズ治療法及びワクチン
FI931393A7 (fi) * 1990-09-27 1993-03-26 Syntello Vaccine Dev Kb Peptidit käytettäväksi rokotuksessa ja neutraloivien vasta-aineiden in duktiossa ihmisen immuunikadon aiheuttavaa virusta vastaan
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
ITRM920350A0 (it) 1992-05-11
ATE188484T1 (de) 2000-01-15
EP0641357B1 (de) 2000-01-05
WO1993023427A1 (en) 1993-11-25
US6042831A (en) 2000-03-28
CA2135630A1 (en) 1993-11-25
EP0641357A1 (de) 1995-03-08
US20020081566A1 (en) 2002-06-27
IT1254360B (it) 1995-09-14
ITRM920350A1 (it) 1993-11-11
DE69327529T2 (de) 2000-08-10
CA2135630C (en) 2005-03-22

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK0724432T3 (da) Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
DE69534528D1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
ATE263189T1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
DK102589A (da) Antigen, der genkendes af mca 16-88
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
DK467181A (da) Virusmutant af shv, vaccine indeholdende denne mutant og fremgangsmaade til fremstilling af vaccinen
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DE60216958D1 (de) Eine den gp41-zwischenzustand imitierende struktur bildendes polypeptid-antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee